Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 2.94B | £ 3.33B | £ 2.75B | £ 2.49B | £ 1.48B |
Total Assets | £ 100.57B | £ 94.86B | £ 88.94B | £ 67.22B | £ 65.78B |
Total Debt | £ 48.59B | £ 45.47B | £ 43.90B | £ 31.22B | £ 32.02B |
Net Debt | £ 45.65B | £ 42.13B | £ 41.14B | £ 28.73B | £ 30.54B |
Total Liabilities | £ 74.62B | £ 71.00B | £ 68.30B | £ 47.36B | £ 47.43B |
Stockholders Equity | £ 25.93B | £ 23.83B | £ 20.62B | £ 19.84B | £ 18.32B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |